Base
Notice2026-111012026-06-03

Third Annual Animal Drug User Fee Educational Conference; Public Meeting

Health and Human Services Department, Food and Drug Administration

Abstract

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following educational conference (public meeting) entitled "Third Annual Animal Drug User Fee Educational Conference." This is the third of five annual educational conferences FDA will host as described in the "Animal Drug User Fee Act Reauthorization Performance Goals and Procedures Fiscal Years 2024 Through 2028." The purpose of this series of conferences is to provide educational sessions for stakeholders who are interested in the new animal drug approval process.

Action & Dates

Action
Notice of public meeting.
Dates
The third educational conference will be held on July 7, 2026, from 9 a.m. to 1 p.m. Eastern Time. See the SUPPLEMENTARY INFORMATION section for registration dates and information. You may submit comments at any time for this series of educational conferences. We request that you submit either electronic or written comments within 90 days after each annual educational conference to ensure that the Agency considers your comment on a topic discussed at that conference.

Public Comment

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2024-N-2602] AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public meeting. SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following educational conference (public meeting) entitled “Third Annual Animal Drug User Fee Educational Conference.” This is the third of five annual educational conferences FDA will host as described in the “Animal Drug User Fee Act Reauthorization Performance Goals and Procedures Fiscal Years 2024 Through 2028.” The purpose of this series of conferences is to provide educational sessions for stakeholders who are interested in the new animal drug approval process. ( printed page 33177) DATES: The third educational conference will be held on July 7, 2026, from 9 a.m. to 1 p.m. Eastern Time. See the SUPPLEMENTARY INFORMATION section for registration dates and information. You may submit comments at any time for this series of educational conferences. We request that you submit either electronic or written comments within 90 days after each annual educational conference to ensure that the Agency considers your comment on a topic discussed at that conference. ADDRESSES: The third educational conference will be available in person and virtually. The in-person conference will be held at the Harvey W. Wiley Federal Building, 5001 Campus Drive, Room 1A-001, College Park, MD 20740. Routine security chec

Read full document on FederalRegister.gov →

Related Documents

Other Federal Register documents from the same docket.

Full Document

Citation: 91 FR 33176